paroxetine has been researched along with femoxetine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costanzo, MJ; Maryanoff, BE; McComsey, DF; Nortey, SO; Shank, RP; Vaught, JL | 1 |
| Kaatz, GW; Kerns, RJ; Wei, P | 1 |
| Brincat, JP; Carosati, E; Cruciani, G; Fravolini, A; Kaatz, GW; Manfroni, G; Patel, D; Raygada, JL; Sabatini, S | 1 |
| McGuirk, J; Muscat, R; Willner, P | 1 |
| Honoré, PL; Honoré, T; Mellerup, ET; Plenge, P | 1 |
| Lassen, JB; Lund, J; Søndergaard, I | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Hansen, JB; Kristiansen, JE | 1 |
| Navrátilová, H; Potácek, M | 1 |
| Bour, P; Navrátilová, H; Setnicka, V; Urbanová, M; Volka, K | 1 |
| Hansen, JB; Kaatz, GW; Kristiansen, JE; Moudgal, VV; Seo, SM | 1 |
11 other study(ies) available for paroxetine and femoxetine
| Article | Year |
|---|---|
Pyrroloisoquinoline antidepressants. 3. A focus on serotonin.
Topics: Animals; Antidepressive Agents; Biological Assay; Biological Transport; Dose-Response Relationship, Drug; Isoquinolines; Mice; Pyrroles; Rats; Serotonin; Structure-Activity Relationship | 1990 |
Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
Topics: Bacterial Proteins; Biological Transport, Active; Drug Resistance, Multiple, Bacterial; Paroxetine; Piperidines; Staphylococcus aureus; Structure-Activity Relationship | 2004 |
Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Ciprofloxacin; Databases, Factual; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Phenyl Ethers; Propanolamines; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides | 2011 |
Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural satiety sequence.
Topics: Animals; Behavior, Animal; Male; Paroxetine; Piperazines; Piperidines; Rats; Receptors, Serotonin; Satiety Response; Serotonin Antagonists | 1992 |
The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
Topics: Animals; Blood Platelets; Humans; Imipramine; In Vitro Techniques; Neurons; Paroxetine; Piperidines; Rats; Serotonin; Structure-Activity Relationship; Synaptosomes | 1987 |
Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
Topics: Animals; Anisoles; Brain; Clomipramine; Diet; Dioxolanes; Female; Male; Motor Activity; p-Chloroamphetamine; Paroxetine; Piperidines; Rats; Serotonin; Serotonin Antagonists | 1980 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia.
Topics: Antibodies, Monoclonal; Antidepressive Agents; Antipsychotic Agents; Cell Line; Flupenthixol; gag Gene Products, Human Immunodeficiency Virus; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV-1; Humans; Immunohistochemistry; Paroxetine; Piperidines; Viral Proteins; Virus Replication | 2000 |
Enantiomeric enrichment of (+)-(3R,4S)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by crystallization.
Topics: Crystallization; Humans; Magnetic Resonance Spectroscopy; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Stereoisomerism | 2001 |
Vibrational circular dichroism spectroscopy study of paroxetine and femoxetine precursors.
Topics: Circular Dichroism; Models, Chemical; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors | 2002 |
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.
Topics: Biological Transport, Active; Drug Resistance, Multiple, Bacterial; Hydrogen-Ion Concentration; Membrane Potentials; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Staphylococcus aureus | 2003 |